glycerolization/deglycerolization centrifugal blood cell processors

Award Notice Posted

Solicitation number
N6264515RCES068
Agency
Awarded
to Haemonetics Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
N6264515P3102 Federal contract award
NAICS code
339112 Surgical and Medical Instrument Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

NOTICE OF INTENT

The Naval Medical Logistics Command intends to negotiate on a sole source basis (IAW FAR 13.501(a)) with Haemonetics Corporation, 400 Wood Road, Braintree, MA 02184, as the only responsible source that can provide four (4) glycerolization/deglycerolization centrifugal blood cell processors equipment that meet the requirements of the government.
Haemonetics Corporation is the sole manufacturer or has exclusive contracts with vendors that manufacture parts for this equipment. As such, Haemonetics Corporation is the only vendor that can provide original equipment manufacturer (OEM) parts for the repair and maintenance of this equipment. Haemonetics Corporation is the only company that has access to OEM-certified parts for repair and to the software updates and upgrades necessary for the equipment. Additionally, Haemonetics Corporation does not certify third parties to maintain their equipment. Haemonetics Corporation is the only company that can provide the maintenance services required by the government for this equipment.
Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor or authorized reseller for the proposed equipment/system such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty and service associated with the equipment/system shall be in accordance with the OEM terms and conditions. The maintenance shall be provided by original equipment manufacturer (OEM)-certified technicians and shall use only OEM-approved replacement parts and proprietary software.
This acquisition is being conducted under simplified acquisition procedures FAR 13.501(a), sole source (including brand name) acquisitions. There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112 with a small business size standard of 500 employees. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.


Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to Deborah Hagan at Deborah.L.Hagan.civ@mail.mil. Statements are due not later than 2:00 p.m. on 21 August 2015 . No phone calls accepted.


 

Notice history

Notice Type Posted
Centrifugal blood cell processors Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity